Juan J. Canales, D.Phil. - Publications

Affiliations: 
University of Canterbury, New Zealand, Christchurch, Canterbury, New Zealand 

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Schwartz MD, Canales JJ, Zucchi R, Espinoza S, Sukhanov I, Gainetdinov RR. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opinion On Therapeutic Targets. PMID 29798691 DOI: 10.1080/14728222.2018.1480723  0.315
2016 Pei Y, Asif-Malik A, Canales JJ. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications. Frontiers in Neuroscience. 10: 148. PMID 27092049 DOI: 10.3389/Fnins.2016.00148  0.336
2015 Pei Y, Mortas P, Hoener MC, Canales JJ. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 63: 70-5. PMID 26048337 DOI: 10.1016/J.Pnpbp.2015.05.014  0.501
2015 Hamilton J, Lee J, Canales JJ. Chronic unilateral stimulation of the nucleus accumbens at high or low frequencies attenuates relapse to cocaine seeking in an animal model. Brain Stimulation. 8: 57-63. PMID 25457212 DOI: 10.1016/J.Brs.2014.09.018  0.4
2014 Pei Y, Lee J, Leo D, Gainetdinov RR, Hoener MC, Canales JJ. Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2299-308. PMID 24722355 DOI: 10.1038/Npp.2014.88  0.504
2014 Ferragud A, Velázquez-Sánchez C, Canales JJ. Modulation of methamphetamine's locomotor stimulation and self-administration by JHW 007, an atypical dopamine reuptake blocker. European Journal of Pharmacology. 731: 73-9. PMID 24675149 DOI: 10.1016/J.Ejphar.2014.03.015  0.768
2013 Velázquez-Sánchez C, García-Verdugo JM, Murga J, Canales JJ. The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 44: 73-80. PMID 23385166 DOI: 10.1016/J.Pnpbp.2013.01.016  0.775
2013 Velázquez-Sánchez C, Ferragud A, Ramos-Miguel A, García-Sevilla JA, Canales JJ. Substituting a long-acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking. Addiction Biology. 18: 633-43. PMID 22741574 DOI: 10.1111/J.1369-1600.2012.00458.X  0.78
2012 Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velázquez-Sánchez C, Sotnikova TD, Morairty SR, Harmeier A, Groebke Zbinden K, Norcross RD, Bradaia A, Kilduff TS, Biemans B, Pouzet B, Caron MG, ... Canales JJ, et al. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biological Psychiatry. 72: 934-42. PMID 22705041 DOI: 10.1016/J.Biopsych.2012.05.014  0.719
2012 Velázquez-Sánchez C, Canales JJ. Atypical dopamine transporter inhibitors: Candidates for the treatment of psychostimulant addiction Emerging Targets For Drug Addiction Treatment. 133-150.  0.725
2011 Velazquez-Sanchez C, Ferragud A, Renau-Piqueras J, Canales JJ. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 655-65. PMID 20735880 DOI: 10.1017/S1461145710000969  0.788
2010 Hernandez-Rabaza V, Navarro-Mora G, Velazquez-Sanchez C, Ferragud A, Marin MP, Garcia-Verdugo JM, Renau-Piqueras J, Canales JJ. Neurotoxicity and persistent cognitive deficits induced by combined MDMA and alcohol exposure in adolescent rats. Addiction Biology. 15: 413-23. PMID 21040238 DOI: 10.1111/J.1369-1600.2010.00259.X  0.714
2010 Velázquez-Sánchez C, Ferragud A, Murga J, Cardá M, Canales JJ. The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 501-8. PMID 20413276 DOI: 10.1016/J.Euroneuro.2010.03.005  0.78
2010 Ferragud A, Haro A, Sylvain A, Velázquez-Sánchez C, Hernández-Rabaza V, Canales JJ. Enhanced habit-based learning and decreased neurogenesis in the adult hippocampus in a murine model of chronic social stress. Behavioural Brain Research. 210: 134-9. PMID 20153381 DOI: 10.1016/J.Bbr.2010.02.013  0.696
2009 Ferragud A, Velázquez-Sánchez C, Hernández-Rabaza V, Nácher A, Merino V, Cardá M, Murga J, Canales JJ. A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat. Psychopharmacology. 207: 281-9. PMID 19756525 DOI: 10.1007/S00213-009-1653-X  0.775
2009 Velázquez-Sánchez C, Ferragud A, Hernández-Rabaza V, Nácher A, Merino V, Cardá M, Murga J, Canales JJ. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2497-507. PMID 19606084 DOI: 10.1038/Npp.2009.78  0.783
2009 Hernández-Rabaza V, Llorens-Martín M, Velázquez-Sánchez C, Ferragud A, Arcusa A, Gumus HG, Gómez-Pinedo U, Pérez-Villalba A, Roselló J, Trejo JL, Barcia JA, Canales JJ. Inhibition of adult hippocampal neurogenesis disrupts contextual learning but spares spatial working memory, long-term conditional rule retention and spatial reversal. Neuroscience. 159: 59-68. PMID 19138728 DOI: 10.1016/J.Neuroscience.2008.11.054  0.7
2009 Ferragud A, Velázquez-Sánchez C, Arcusa A, Hernández-Rabaza V, Gumus H, Nácher A, Merino V, Murga J, Cardá M, Canales J. P.6.d.017 Profile of the N-substituted benztropine analog, AHN-1055, as a candidate treatment for cocaine addiction European Neuropsychopharmacology. 19: S667. DOI: 10.1016/S0924-977X(09)71076-4  0.75
2009 Velázquez-Sanchez C, Ferragud A, Hernandez-Rabaza V, Arcusa A, Gumus H, Nácher A, Merino V, Cardá M, Murga J, Canales J. P6.C.0111 Effectiveness of the benztropine analogs in preventing the neurochemical and behavioural effects of psychostimulants European Neuropsychopharmacology. 19: S656. DOI: 10.1016/S0924-977X(09)71057-0  0.699
2008 Hernández-Rabaza V, Hontecillas-Prieto L, Velázquez-Sánchez C, Ferragud A, Pérez-Villaba A, Arcusa A, Barcia JA, Trejo JL, Canales JJ. The hippocampal dentate gyrus is essential for generating contextual memories of fear and drug-induced reward. Neurobiology of Learning and Memory. 90: 553-9. PMID 18644245 DOI: 10.1016/J.Nlm.2008.06.008  0.736
2007 Del Arco A, Segovia G, Canales JJ, Garrido P, de Blas M, García-Verdugo JM, Mora F. Environmental enrichment reduces the function of D1 dopamine receptors in the prefrontal cortex of the rat. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 43-8. PMID 16955373 DOI: 10.1007/S00702-006-0565-8  0.359
2002 Canales JJ, Capper-Loup C, Hu D, Choe ES, Upadhyay U, Graybiel AM. Shifts in striatal responsivity evoked by chronic stimulation of dopamine and glutamate systems. Brain : a Journal of Neurology. 125: 2353-63. PMID 12244091 DOI: 10.1093/Brain/Awf239  0.606
2002 Capper-Loup C, Canales JJ, Kadaba N, Graybiel AM. Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6218-27. PMID 12122080 DOI: 10.1523/Jneurosci.22-14-06218.2002  0.626
2001 Graybiel AM, Canales JJ. The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome. Advances in Neurology. 85: 123-31. PMID 11530422  0.405
2000 Canales JJ, Iversen SD. Psychomotor-activating effects mediated by dopamine D(2) and D(3) receptors in the nucleus accumbens. Pharmacology, Biochemistry, and Behavior. 67: 161-8. PMID 11113496 DOI: 10.1016/S0091-3057(00)00311-7  0.535
2000 Graybiel AM, Canales JJ, Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends in Neurosciences. 23: S71-7. PMID 11052223 DOI: 10.1016/S1471-1931(00)00027-6  0.553
2000 Canales JJ, Iversen SD. Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors. Synapse (New York, N.Y.). 36: 297-306. PMID 10819907 DOI: 10.1002/(Sici)1098-2396(20000615)36:4<297::Aid-Syn6>3.0.Co;2-M  0.553
2000 Canales JJ, Graybiel AM. Patterns of gene expression and behavior induced by chronic dopamine treatments. Annals of Neurology. 47: S53-9. PMID 10762132  0.547
2000 Canales JJ, Graybiel AM. A measure of striatal function predicts motor stereotypy. Nature Neuroscience. 3: 377-83. PMID 10725928 DOI: 10.1038/73949  0.549
2000 Canales JJ, Gilmour G, Iversen SD. The role of nigral and thalamic output pathways in the expression of oral stereotypies induced by amphetamine injections into the striatum. Brain Research. 856: 176-83. PMID 10677624 DOI: 10.1016/S0006-8993(99)02344-6  0.55
1998 Canales JJ, Iversen SD. Behavioural topography in the striatum: differential effects of quinpirole and D-amphetamine microinjections. European Journal of Pharmacology. 362: 111-9. PMID 9874160 DOI: 10.1016/S0014-2999(98)00752-3  0.558
1998 Kawasaki H, Springett GM, Toki S, Canales JJ, Harlan P, Blumenstiel JP, Chen EJ, Bany IA, Mochizuki N, Ashbacher A, Matsuda M, Housman DE, Graybiel AM. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proceedings of the National Academy of Sciences of the United States of America. 95: 13278-83. PMID 9789079 DOI: 10.1073/Pnas.95.22.13278  0.468
Show low-probability matches.